Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

ATTRwt-CM has a distinctly different biomarker profile compared with HFpEF/HFmrEF, while ATTRwt-CM patients share a similar biomarker profile with AL-CM patients characterized by up-regulation of proteoglycans and cell-adhesion pathways. The biomarkers DCN and IDUA show the potential to serve as an initial screening tool for ATTTRwt-CM. Further research is needed to determine the clinical usefulness of these and other extracellular matrix components in identifying ATTRwt-CM.

Authors

Institutions

Publication Details

Journal
Cardiovascular Research
Published
2024-09-17
DOI
https://doi.org/10.1093/cvr/cvae189
Citations
6
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Riemer H. J. A. Slart, Hans Nienhuis, Bouke P. C. Hazenberg, Laura M G Meems et al.
6 citations
Cardiovascular Research
Amyloidosis: Diagnosis, Treatment, Outcomes
1.40
article

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF

Riemer H. J. A. Slart, Hans Nienhuis, Bouke P. C. Hazenberg, Laura M G Meems, Lukas Baumhove, Johan Bijzet, George Markousis‐Mavrogenis, Alwin Tubben, Bart J. van Essen, Dirk Jan van Veldhuisen, Adriaan A. Voors, Milou Berends, Hendrea S. A. Tingen, Peter van der Meer
article en
6 citations

Abstract

ATTRwt-CM has a distinctly different biomarker profile compared with HFpEF/HFmrEF, while ATTRwt-CM patients share a similar biomarker profile with AL-CM patients characterized by up-regulation of proteoglycans and cell-adhesion pathways. The biomarkers DCN and IDUA show the potential to serve as an initial screening tool for ATTTRwt-CM. Further research is needed to determine the clinical usefulness of these and other extracellular matrix components in identifying ATTRwt-CM.

Cardiovascular ResearchVol. 120(14)
University Medical Center Groningen (NL), Amyloidosis Foundation (US)
Reduced inequalities
Openalex Percentile: Top 19%
Amyloidosis: Diagnosis, Treatment, Outcomes
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF — Riemer H. J. A. Slart, Hans Nienhuis, et al. · Cardiovascular Research (2024) | TGRS Research Map | TGRS